Literature DB >> 24662325

The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cells.

Javid A Dar1, Khalid Z Masoodi2, Kurtis Eisermann2, Sudhir Isharwal2, Junkui Ai2, Laura E Pascal2, Joel B Nelson3, Zhou Wang4.   

Abstract

Androgen-independent nuclear localization is required for androgen receptor (AR) transactivation in castration-resistant prostate cancer (CRPC) and should be a key step leading to castration resistance. However, mechanism(s) leading to androgen-independent AR nuclear localization are poorly understood. Since the N-terminal domain (NTD) of AR plays a role in transactivation under androgen-depleted conditions, we investigated the role of the NTD in AR nuclear localization in CRPC. Deletion mutagenesis was used to identify amino acid sequences in the NTD essential for its androgen-independent nuclear localization in C4-2, a widely used CRPC cell line. Deletion mutants of AR tagged with green fluorescent protein (GFP) at the 5'-end were generated and their signal distribution was investigated in C4-2 cells by fluorescent microscopy. Our results showed that the region of a.a. 294-556 was required for androgen-independent AR nuclear localization whereas a.a. 1-293 mediates Hsp90 regulation of AR nuclear localization in CRPC cells. Although the region of a.a. 294-556 does not contain a nuclear import signal, it was able to enhance DHT-induced import of the ligand binding domain (LBD). Also, transactivation of the NTD could be uncoupled from its modulation of AR nuclear localization in C4-2 cells. These observations suggest an important role of the NTD in AR intracellular trafficking and androgen-independent AR nuclear localization in CRPC cells.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24662325      PMCID: PMC4127361          DOI: 10.1016/j.jsbmb.2014.03.004

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  48 in total

1.  Impaired nuclear translocation, nuclear matrix targeting, and intranuclear mobility of mutant androgen receptors carrying amino acid substitutions in the deoxyribonucleic acid-binding domain derived from androgen insensitivity syndrome patients.

Authors:  Hisaya Kawate; Yin Wu; Keizo Ohnaka; Rong-Hua Tao; Kei-Ichiro Nakamura; Taijiro Okabe; Toshihiko Yanase; Hajime Nawata; Ryoichi Takayanagi
Journal:  J Clin Endocrinol Metab       Date:  2005-08-23       Impact factor: 5.958

2.  Interplay between two hormone-independent activation domains in the androgen receptor.

Authors:  Leen Callewaert; Nora Van Tilborgh; Frank Claessens
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

3.  Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain.

Authors:  N L Chamberlain; D C Whitacre; R L Miesfeld
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

4.  Mutation of the androgen receptor causes oncogenic transformation of the prostate.

Authors:  Guangzhou Han; Grant Buchanan; Michael Ittmann; Jonathan M Harris; Xiaoqing Yu; Francesco J Demayo; Wayne Tilley; Norman M Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-18       Impact factor: 11.205

5.  Identification of two transcription activation units in the N-terminal domain of the human androgen receptor.

Authors:  G Jenster; H A van der Korput; J Trapman; A O Brinkmann
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

Review 6.  Androgen receptor transactivation domain and control of spermatogenesis.

Authors:  E L Yong; F Ghadessy; Q Wang; A Mifsud; S C Ng
Journal:  Rev Reprod       Date:  1998-09

7.  Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism.

Authors:  Michelle Welsh; Philippa T K Saunders; Mark Fisken; Hayley M Scott; Gary R Hutchison; Lee B Smith; Richard M Sharpe
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

8.  Structural basis for the nuclear import of the human androgen receptor.

Authors:  Mark L Cutress; Hayley C Whitaker; Ian G Mills; Murray Stewart; David E Neal
Journal:  J Cell Sci       Date:  2008-03-04       Impact factor: 5.285

9.  Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.

Authors:  W D Tilley; G Buchanan; T E Hickey; J M Bentel
Journal:  Clin Cancer Res       Date:  1996-02       Impact factor: 12.531

Review 10.  Androgen receptor and Kennedy disease/spinal bulbar muscular atrophy.

Authors:  Douglas Ashley Monks; Pengcheng Rao; Kaiguo Mo; Jamie Ann Johansen; Gareth Lewis; Michael Quentin Kemp
Journal:  Horm Behav       Date:  2008-01-05       Impact factor: 3.587

View more
  7 in total

1.  A new compound targets the AF-1 of androgen receptor and decreases its activity and protein levels in prostate cancer cells.

Authors:  Tuyen Thanh Tran; Chin-Hee Song; Kyung-Jin Kim; Keesook Lee
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

2.  Splicing Factor Prp8 Interacts With NES(AR) and Regulates Androgen Receptor in Prostate Cancer Cells.

Authors:  Dan Wang; Minh M Nguyen; Khalid Z Masoodi; Prabhpreet Singh; Yifeng Jing; Katherine O'Malley; Javid A Dar; Rajiv Dhir; Zhou Wang
Journal:  Mol Endocrinol       Date:  2015-09-15

3.  Inhibition of Androgen Receptor Nuclear Localization and Castration-Resistant Prostate Tumor Growth by Pyrroloimidazole-based Small Molecules.

Authors:  Khalid Z Masoodi; Yadong Xu; Javid A Dar; Kurtis Eisermann; Laura E Pascal; Erica Parrinello; Junkui Ai; Paul A Johnston; Joel B Nelson; Peter Wipf; Zhou Wang
Journal:  Mol Cancer Ther       Date:  2017-06-27       Impact factor: 6.261

4.  Development and Implementation of a High-Throughput High-Content Screening Assay to Identify Inhibitors of Androgen Receptor Nuclear Localization in Castration-Resistant Prostate Cancer Cells.

Authors:  Paul A Johnston; Minh M Nguyen; Javid A Dar; Junkui Ai; Yujuan Wang; Khalid Z Masoodi; Tongying Shun; Sunita Shinde; Daniel P Camarco; Yun Hua; Donna M Huryn; Gabriela Mustata Wilson; John S Lazo; Joel B Nelson; Peter Wipf; Zhou Wang
Journal:  Assay Drug Dev Technol       Date:  2016-05       Impact factor: 1.738

5.  Hsp70 Binds to the Androgen Receptor N-terminal Domain and Modulates the Receptor Function in Prostate Cancer Cells.

Authors:  Jun Dong; Zeyu Wu; Dan Wang; Laura E Pascal; Joel B Nelson; Peter Wipf; Zhou Wang
Journal:  Mol Cancer Ther       Date:  2018-10-08       Impact factor: 6.261

Review 6.  Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective.

Authors:  Jian Huang; Biyun Lin; Benyi Li
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

Review 7.  A sting in the tail: the N-terminal domain of the androgen receptor as a drug target.

Authors:  Amy E Monaghan; Iain J McEwan
Journal:  Asian J Androl       Date:  2016 Sep-Oct       Impact factor: 3.285

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.